Health Law

The Health Law attorneys at Wilentz, Goldman & Spitzer, P.A. offer deep experience across a range of health law needs, with strong capabilities in all aspects of strategy and operations, regulatory counseling, healthcare financing, and transactions.

We provide advice relating to cutting-edge legal issues facing health law participants, representation in connection with entity formation, strategic transactions and guidance on the complex regulatory and operational landscape facing those conducting business in the healthcare sector. Our practice earns high rankings across peer-reviewed publications, including Chambers USA. 

Chambers USA® (https://chambers.com/about-us/methodology) is published by Chambers and Partners.

A description of the selection process may be accessed via the above link. The aforementioned organization is a private peer review organization, not court-specific, public certification vehicles. No aspect of this advertisement has been submitted to or approved by the Supreme Court of New Jersey.

We represent a broad range of healthcare providers, and our team serves as general counsel to dozens of healthcare entities, from individual healthcare practitioners to whole healthcare systems. Our lawyers have practiced at the forefront of healthcare law for decades, advising on a variety of emerging developments in health law, such as telemedicine, and Clinically Integrated Networks (“CINs”). Wilentz's experience in the health sector is based on both our knowledge of the law impacting our healthcare clients and our in-depth understanding of the commercial, regulatory, and operational issues involved in building and growing successful healthcare businesses. 

We represent physicians, dentists, and other healthcare providers and entities on the formation and structure of their practice and in connection with joint ventures, corporations, partnerships, and limited liability companies. We handle all aspects of sales, purchases, mergers and acquisitions of healthcare entities, and related licensure issues.

We also represent private equity and venture capital funds in connection with acquisitions, dispositions, joint ventures, and investment opportunities in health-related entities.